The Impact of AI-Assisted Nursing Care Intervention Within the Enhanced Recovery Framework on Outcomes of Colorectal Surgery Patients

June 6, 2026 updated by: Özlem Kıvanç, Bahçeşehir University

The Impact of AI-Powered Video-Based Discharge Education and Follow-up Intervention on Patient Outcomes and Home Care Management in Colorectal Surgery Patients Receiving Care in Line With the Postoperative Accelerated Recovery Protocol: A Mixed Methods Study

Colorectal cancer is one of the most common cancers worldwide, affecting a large number of people each year (Bray et al., 2022). Surgical intervention remains the gold standard in treatment. However, advances in surgical techniques and increased effectiveness of neoadjuvant therapies have brought sphincter-preserving surgeries to the forefront, reducing the need for stoma creation compared to the past (Jo & Wilson, 2025; Wang et al., 2025). Even without stoma creation, these patients face complex care needs in the post-discharge period, including changes in bowel habits, nutritional management, and adaptation to physical activity (Wang et al., 2025). Difficult-to-manage complications carry a high risk of readmission to the hospital. Patients receive limited support during the transition from the hospital to home and at home (Storm et al., 2024). Patients and their families are often left alone to manage home care until routine follow-up appointments. Patients, especially those poorly prepared for discharge, may not know how to perform care practices at home or what to watch out for in case of complications. Situations that are well managed in the hospital can spiral out of control upon inadequate follow-up after the patient returns home, leading to unplanned readmissions. Insufficient postoperative patient follow-up can cause anxiety in patients, leading to readmissions due to the inability to manage the home care process effectively (Storm et al., 2024).

Although accelerated recovery after surgery (ERAS) is known to shorten hospital stays (Gustafsson et al., 2025; Gustafsson et al., 2019), studies show varying results regarding readmissions, re-operations, developing complications, and survival (Coleman et al., 2006; Takchi et al., 2020; Lee et al., 2022). These variable results highlight the need for a structured discharge process and home care management for patients who undergo ERAS and are discharged home earlier. In the study by Takchi et al. (2020), a scheduled phone call was proposed as the final step in advanced recovery recommendations and presented as a pilot study. The study reported that each patient contacted reported at least one symptom and personal care need (Takchi et al., 2020). The scheduled phone calls proposed by Takchi et al. (2020) are an important monitoring mechanism in the recovery process; however, they are insufficient.

Supporting this monitoring process with a structured discharge management and AI-powered digital video accessible to the patient at any time, extends the continuity of care to a digital dimension.

It is reported that AI-powered multimedia tools, whose use is increasing with the transformation in health technologies today, reduce cognitive load by concretizing complex surgical processes with audiovisual materials and improve patients' self-care skills regardless of their health literacy level (Mendoza-Pinto et al., 2025). "Content prepared with generative artificial intelligence algorithms, in particular, increases the retention of information and the patient's digital health literacy compared to traditional educational materials (Zaretsky et al., 2024). This study aims to both structure the discharge and post-discharge follow-up process, which is included in ERAS protocols to a limited extent, and to increase the patient's readiness for discharge, improve patient outcomes, and facilitate home care management using AI-assisted educational videos. Thus, the study significantly points to a fourth step, which is included in ERAS guidelines in the pre-operative, intra-operative, and post-operative phases and is felt to be missing: the discharge and home follow-up process.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Istanbul
      • Istanbul, Istanbul, Turkey (Türkiye), 34050
        • Acıbadem Maslak Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Agreement to participate in the study Being 18 years of age or older Ability to communicate in Turkish No visual or hearing impairment No cognitive impairment Undergoing elective colorectal surgery in accordance with an accelerated postoperative recovery protocol

Exclusion Criteria:

Patients who did not meet the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Routine information, standard care, and follow-up after hospital discharge.
Other: Standard maintenance therapy
Routine postoperative care and standard hospital discharge education are provided in accordance with institutional protocols. Routine care includes a general postoperative recovery assessment, complication screening, and standard follow-up visits without AI-assisted video training or a scheduled telephone follow-up program.
Experimental: intervention group
A structured, AI-powered, video-based discharge education program is supported by scheduled follow-up phone calls on days 3, 7, 10, and 30 post-surgery. An in-depth qualitative interview is also conducted on day 30.
Behavioral: Educational intervention
A structured discharge education program is supported by video-based training and scheduled follow-up phone calls on days 3, 7, 10, and 30 post-operatively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
KATZ Activities of Daily Living (ADL) Scale
Time Frame: Baseline (pre-discharge) and postoperative day 30
If the individual can do their ADL independently, they are given 3 points, if they are partially assisted, they are given 2 points, if they cannot do it at all, they are given 1 point and the evaluation is made accordingly. In the evaluation made according to this scale, 0-6 points are evaluated as dependent, 7-12 points as partially dependent, and 13-18 points as independent. Accordingly, as the score obtained from the scale increases, dependency decreases.
Baseline (pre-discharge) and postoperative day 30
Readiness for Discharge Scale
Time Frame: Up to 30 days after the patient's hospitalization date.
If the scale dimensions score was ≥7, the patient was considered ready for discharge, and if it was <7, it was considered not ready.
Up to 30 days after the patient's hospitalization date.
Gastrointestinal Quality of Life Index (GIQLI)
Time Frame: Baseline (pre-discharge) and postoperative day 30
The scale is a 5-point Likert-type scale consisting of 36 items, scored between 0 and 4. While the original scale included sub-dimensions of symptoms, emotions, physical functions, and social functions, the factor analysis conducted in the Turkish validity study revealed a 7-factor structure (sub-dimensions). The total score obtainable from the scale ranges from 0 to 144. A higher total score on the scale indicates an improvement in the patient's quality of life specific to the gastrointestinal system and an improvement in their health status.
Baseline (pre-discharge) and postoperative day 30

Secondary Outcome Measures

Outcome Measure
Time Frame
Day of hospital stay
Time Frame: Up to 30 days after the patient's hospitalization date.
Up to 30 days after the patient's hospitalization date.
complications
Time Frame: Up to postoperative day 30
Up to postoperative day 30
Readmisson
Time Frame: Within 30 days after discharge
Within 30 days after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bahçeşehir University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

May 16, 2025

First Submitted That Met QC Criteria

January 22, 2026

First Posted (Actual)

January 27, 2026

Study Record Updates

Last Update Posted (Actual)

June 9, 2026

Last Update Submitted That Met QC Criteria

June 6, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Approval number 2026-07/290

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data is patient specific, therefore, other data will not be shared except for the research results.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Surgery

Clinical Trials on Standard maintenance therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe